ImmunoPRISM Trial Shows Teclistamab Improves Depth of Response and Progression-Free Survival in High-Risk Smoldering Multiple Myeloma
-
By
-
June 14, 2026
-
4 min
By
June 14, 2026
by
June 14, 2026
Board-certified obstetrics and gynecology physician and fellowship-trained urogynecologist Christina Mezes, D.O., has joined the Christine E. Lynn Women’s Health & Wellness Institute in Boca Raton, a part of Baptist Health South Florida.
by Serdar Gumus
November 5, 2026
Higher proportions of less-differentiated T cells were associated with longer progression-free survival in a 783-patient lymphoma analysis
November 4, 2026